Outcomes after liver cancer rupture
Part of Cancer clinical trials.
This study looks at what happens to people whose liver cancer (HCC) ruptures on its own, to help doctors predict outcomes and improve care. Participation involves sharing your medical records and imaging data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with liver cancer (called HCC).
- Your liver tumor ruptured on its own, without injury.
- You are currently admitted to the hospital.
- The rupture was not caused by trauma or accident, and you do not have another liver cancer type.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study reviews medical records of people diagnosed with hepatocellular carcinoma (liver cancer) between 2015 and 2023 to better understand how the disease progresses and how different treatments work. Your information helps researchers learn what care approaches work best for future patients.
This study uses non-invasive tests, like scans or blood tests, to predict how well people with liver cancer (hepatocellular carcinoma, or HCC) will do after curative treatment. It may help doctors better understand your condition without needing invasive procedures.
This study tracks patients with liver cancer who have had surgery to see how often the cancer comes back. It may help doctors better understand and predict recurrence.
This study looks back at medical records of people who had liver cancer (HCC) and had either a transplant or surgery to remove the tumor. It aims to improve a tool that helps predict how well a patient may do, which could guide future treatment decisions.
This study looks at genetic markers in the blood of people with liver cancer who are having surgery, either right away or after some treatment first. It aims to find out why some patients do better, which could help personalize care.
This trial uses a computer model to predict if your liver cancer might come back aggressively after surgery. If you are at high risk, you may receive additional treatment before surgery to lower that risk.
Hear when a new HCC Rupture trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.